查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387032

女性健康檢查市場報告：2030年趨勢、預測與競爭分析

Womens Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

女性健康檢查趨勢及預測

預計到 2030 年，全球女性健康診斷市場將達到 488.2 億美元，2024 年至 2030 年年複合成長率為 8.1%。該市場的主要驅動力是女性感染疾病的高盛行率以及 POC 檢測的不斷成長的跡象。全球女性健康診斷市場的未來前景廣闊，醫院/診所、診斷/影像中心和家庭護理市場存在商機。

女性健康診斷市場洞察

Lucintel 預測，由於乳癌的高發生率以及人們對 ABS 等先進乳癌診斷技術的認知不斷增強，預計乳癌在預測期內將出現最高成長。

由於使用自檢檢測套組的好處越來越多，居家醫療仍然是市場上最大的部分。

由於女性癌症盛行率不斷上升，預計北美在預測期內將經歷最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球女性健康診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球女性健康檢查市場趨勢（2018-2023）及預測（2024-2030）
  • 按最終用途產業分類的全球女性健康診斷市場
    • 醫院和診所
    • 診斷中心及影像中心
    • 居家照護
    • 其他
  • 全球女性健康診斷市場（按應用）
    • 骨質疏鬆測試
    • OVC測試
    • 子宮頸癌測試
    • 乳癌檢查
    • 妊娠及不孕症檢測
    • 產前基因篩檢和基因帶原檢測
    • 傳染病檢查
    • 性病測試
    • 超音波檢查

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球女性健康檢查市場（按地區）
  • 北美女性健康檢查市場
  • 歐洲女性健康檢查市場
  • 亞太女性健康檢查市場
  • 其他地區女性健康體檢市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球女性健康診斷市場最終用途產業的成長機會
    • 全球女性健康診斷市場的成長機會（按應用）
    • 按地區分類的全球女性健康診斷市場成長機會
  • 全球女性健康檢查市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球女性健康診斷市場的容量
    • 全球女性健康診斷市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • F. Hoffmann-la Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • Ge Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic
簡介目錄

Womens Health Diagnostic Trends and Forecast

The future of the global womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets. The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

A more than 150-page report is developed to help in your business decisions.

Womens Health Diagnostic by Segment

The study includes a forecast for the global womens health diagnostic by end use industry, application, and region.

Womens Health Diagnostic Market by End Use Industry Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic & Imaging Centers
  • Home Care Settings
  • Others

Womens Health Diagnostic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Osteoporosis Testing
  • OVC Testing
  • Cervical Cancer Testing
  • Breast Cancer Testing
  • Pregnancy & Fertility Testing
  • Prenatal Genetic Screening & Carrier Testing
  • Infectious Disease Testing
  • STD Testing
  • Ultrasound Tests
  • Others

Womens Health Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Womens Health Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies womens health diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the womens health diagnostic companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • GE Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic

Womens Health Diagnostic Market Insights

Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Within this market, home care settings will remain the largest segment due to increasing advantages of using self-testing kits.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Features of the Global Womens Health Diagnostic Market

Market Size Estimates: Womens health diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Womens health diagnostic market size by end use industry, application, and region in terms of value ($B).

Regional Analysis: Womens health diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different end use industry, application, and regions for the womens health diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the womens health diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the womens health diagnostic market size?

Answer: The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030.

Q.2 What is the growth forecast for womens health diagnostic market?

Answer: The global womens health diagnostic market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the womens health diagnostic market?

Answer: The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

Q4. What are the major segments for womens health diagnostic market?

Answer: The future of the womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets.

Q5. Who are the key womens health diagnostic market companies?

Answer: Some of the key womens health diagnostic companies are as follows:

  • F. Hoffmann-La Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • Ge Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic

Q6. Which womens health diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Q7. In womens health diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the womens health diagnostic market by end use industry (hospitals & clinics, diagnostic & imaging centers, home care settings, and others), application (osteoporosis testing, ovc testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Womens Health Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Womens Health Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Womens Health Diagnostic Market by End Use Industry Industry
    • 3.3.1: Hospitals & Clinics
    • 3.3.2: Diagnostic & Imaging Centers
    • 3.3.3: Home Care Settings
    • 3.3.4: Others
  • 3.4: Global Womens Health Diagnostic Market by Application
    • 3.4.1: osteoporosis testing
    • 3.4.2: OVC testing
    • 3.4.3: cervical cancer testing
    • 3.4.4: breast cancer testing
    • 3.4.5: pregnancy & fertility testing
    • 3.4.6: prenatal genetic screening & carrier testing
    • 3.4.7: infectious disease testing
    • 3.4.8: STD testing
    • 3.4.9: ultrasound tests

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Womens Health Diagnostic Market by Region
  • 4.2: North American Womens Health Diagnostic Market
    • 4.2.2: North American Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.3: European Womens Health Diagnostic Market
    • 4.3.1: European Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.3.2: European Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.4: APAC Womens Health Diagnostic Market
    • 4.4.1: APAC Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.4.2: APAC Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.5: ROW Womens Health Diagnostic Market
    • 4.5.1: ROW Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.5.2: ROW Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Womens Health Diagnostic Market by End Use Industry Industry
    • 6.1.2: Growth Opportunities for the Global Womens Health Diagnostic Market by Application
    • 6.1.3: Growth Opportunities for the Global Womens Health Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Womens Health Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Womens Health Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Womens Health Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-la Roche
  • 7.2: Siemens Aktiengesellschaft
  • 7.3: Quest Diagnostics Incorporated
  • 7.4: Ge Healthcare
  • 7.5: Koninklijke Philips
  • 7.6: General Motors
  • 7.7: Abbott Laboratories
  • 7.8: Becton
  • 7.9: Dickinson
  • 7.10: Hologic